Skip to main content
Premium Trial:

Request an Annual Quote

Clark Withholds $60M Pledge to Bio-X

NEW YORK, Aug. 31 – Entrepreneur and philanthropist Jim Clark struck out against President Bush’s stem cell policy today by announcing that he will withhold $60 million of a $150 million pledge to Stanford University’s Bio-X program, an interdisciplinary biomedical research initiative.

Clark’s suspension of funding, according to Stanford University, is “to protest evolving federal policies and restrictions on stem cell research and potentially on non-reproductive cloning.”

While Clark’s suspension will not immediately affect the Bio-X program as Stanford has already received $90 million from Clark to construct the center, according to Bio-X director James Spudich, the restrictions that Clark is protesting could affect long-term avenues available for genomics research.

“If one has stem cells changing and differentiating, one would use genomics to analyze expression patterns,” Spudich told GenomeWeb . “It you don’t have cells, you can’t do that.”

“Stem cells, like recombinant DNA, can be a tool to explore the genome,” Paul Berg, emeritus professor at Stanford Medical School and Nobel laureate, told GenomeWeb . “Everything impinges on genomics and proteomics, it is the central thing in life. Gene function [studies] in stem cell lines could be affected” by Bush’s policy.

Commenting on Clark’s payment suspension, Berg said, “It sends a message and hopefully it will be heard in Washington.”

Clark, a former Stanford faculty member, went on to found the companies Silicon Graphics, Netscape, and Healtheon.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.